Objective:

To summarize hepatic encephalopathy (HE) as a multi-organ syndrome and discuss its pathophysiology, diagnosis, treatment, and clinical implications, emphasizing its significance in cirrhosis management.

Key Findings:

• CHE affects approximately 40.9% of patients with cirrhosis and is associated with significant cognitive decline, impacting quality of life.
• CHE is a precursor to overt hepatic encephalopathy (OHE), with a 10% annual incidence rate of progression, underscoring the need for early intervention.
• Ammonia plays a central role in CHE pathophysiology, affecting brain function and leading to neuroinflammation, which has critical implications for patient management.

Interpretation:

CHE should be recognized as a complex syndrome involving interactions between the liver, gut, muscle, and brain, necessitating a comprehensive management approach that includes interdisciplinary collaboration.

Limitations:

• Many patients remain undiagnosed due to challenges in testing and treatment, including the need for specialized assessments.
• Current understanding of CHE's pathophysiology is still evolving, requiring further research to address knowledge gaps.

Conclusion:

Effective management of CHE requires an integrated approach addressing its multi-organ nature, with an emphasis on routine screening, evidence-based therapies, and ongoing research to improve outcomes.